Just for sharing:
1. High Success Rates: ALPHA’s IVF success rate is 82.5%, with a 100% success rate in embryo cryopreservation, significantly above the global average.
2. Strong Financial Performance:
• Revenue Growth: Revenue increased from RM62.1 million in FY2021 to RM137.5 million in FY2023, a growth of 121.5%.
• Profit Growth: Net profit soared from RM2.3 million in FY2021 to RM54.8 million in FY2023, a 2,282.6% increase.
• Profit Margins: Gross profit margin increased to 55.8%, and net profit margin surged to 39.9%.
3. Recent Performance: In the first three quarters of FY2024, ALPHA’s net profit was RM39.8 million, already 72.6% of the total for FY2023, indicating continued growth.